Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
2018 · Nature Genetics · 994 citations
https://doi.org/10.1038/s41588-018-0142-8
H
Hui‐Yi Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
463
Papers
15.0K
Citations
60
h-index
211
i10-index
Hui‐Yi Lin is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Genetic Associations and Epidemiology & Cancer-related molecular mechanisms research. The author has an h-index of 60, co-authored 394 publications.
ORCID: 0000-0002-3307-5549Papers by this author
worksCommon Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
2015 · PLoS ONE · 906 citations
https://doi.org/10.1371/journal.pone.0128106
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
2021 · Nature Genetics · 484 citations
https://doi.org/10.1038/s41588-020-00748-0
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
2015 · Nature Genetics · 259 citations
https://doi.org/10.1038/ng.3185
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
2010 · JNCI Journal of the National Cancer Institute · 240 citations
https://doi.org/10.1093/jnci/djq442
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
2023 · Nature Genetics · 131 citations
https://doi.org/10.1038/s41588-023-01534-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat